SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a report published on Monday. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright reissued a buy rating and issued a $3.50 target price on shares of SenesTech in a research report on Tuesday, May 14th.

Get Our Latest Stock Report on SNES

SenesTech Stock Performance

SNES opened at $0.64 on Monday. The business has a 50 day simple moving average of $0.74 and a two-hundred day simple moving average of $0.85. The company has a quick ratio of 5.69, a current ratio of 6.91 and a debt-to-equity ratio of 0.03. SenesTech has a one year low of $0.52 and a one year high of $16.08.

SenesTech (NASDAQ:SNESGet Free Report) last announced its earnings results on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.34) by ($0.02). SenesTech had a negative return on equity of 181.46% and a negative net margin of 545.82%. The firm had revenue of $0.42 million during the quarter, compared to the consensus estimate of $0.43 million. During the same period in the prior year, the company posted ($15.85) EPS. As a group, equities research analysts anticipate that SenesTech will post -1.1 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in SenesTech stock. Armistice Capital LLC purchased a new position in SenesTech, Inc. (NASDAQ:SNESFree Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 70,425 shares of the company’s stock, valued at approximately $30,000. Armistice Capital LLC owned about 1.94% of SenesTech as of its most recent SEC filing. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About SenesTech

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Featured Stories

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.